Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Simon Fifer, Thames Kularatne, Marcus Tan, Fraser Drummond & John Rule. (2023) Understanding Treatment Preferences Among People Living with HIV in Australia: A Discrete Choice Experiment. Patient Preference and Adherence 17, pages 1825-1843.
Read now
Read now
Jan Ostermann, Bernard Njau, Amy M. Hobbie, Tara B. Mtuy, Max Masnick, Derek S. Brown, Axel C. Mühlbacher & Nathan M. Thielman. (2023) Divergent preferences for enhanced HIV testing options among high-risk populations in northern Tanzania: a short report. AIDS Care 35:9, pages 1270-1278.
Read now
Read now
Hiba EL Masri, Treasure M McGuire, Mieke L van Driel, Helen Benham & Samantha A Hollingworth. (2022) Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review. Patient Preference and Adherence 16, pages 2609-2637.
Read now
Read now
Kathleen Beusterien, Jessica Grinspan, Thomas Tencer, Adam Brufsky & Constance Visovsky. (2012) Patient preferences for chemotherapies used in breast cancer. International Journal of Women's Health 4, pages 279-287.
Read now
Read now
Articles from other publishers (18)
Basem Al-Omari, Joviana Farhat & Mujahed Shraim. (2023) The Role of Web-Based Adaptive Choice-Based Conjoint Analysis Technology in Eliciting Patients’ Preferences for Osteoarthritis Treatment. International Journal of Environmental Research and Public Health 20:4, pages 3364.
Crossref
Crossref
Andrew D. Kerkhoff, Charles Muiruri, Elvin H. Geng & Matthew D. Hickey. (2023) A world of choices: preference elicitation methods for improving the delivery and uptake of HIV prevention and treatment. Current Opinion in HIV and AIDS 18:1, pages 32-45.
Crossref
Crossref
Jan Ostermann, Brian P. Flaherty, Derek S. Brown, Bernard Njau, Amy M. Hobbie, Tara B. Mtuy, Max Masnick, Axel C. Mühlbacher & Nathan M. Thielman. (2021) What factors influence HIV testing? Modeling preference heterogeneity using latent classes and class-independent random effects. Journal of Choice Modelling 40, pages 100305.
Crossref
Crossref
Yihalem Abebe Belay, Mezgebu Yitayal, Asmamaw Atnafu & Fitalew Agimass Taye. (2021) Patients’ preferences for antiretroviral therapy service provision: a systematic review. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Crossref
Jan Ostermann, Bernard Njau, Amy Hobbie, Tara Mtuy, Martha L Masaki, Aisa Shayo, Marco van Zwetselaar, Max Masnick, Brian Flaherty, Derek S Brown, Axel C Mühlbacher & Nathan M Thielman. (2020) Using discrete choice experiments to design interventions for heterogeneous preferences: protocol for a pragmatic randomised controlled trial of a preference-informed, heterogeneity-focused, HIV testing offer for high-risk populations. BMJ Open 10:11, pages e039313.
Crossref
Crossref
Jan Ostermann, Axel Mühlbacher, Derek S. Brown, Dean A. Regier, Amy Hobbie, Andrew Weinhold, Noor Alshareef, Caroline Derrick & Nathan M. Thielman. (2020) Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment. Value in Health 23:7, pages 851-861.
Crossref
Crossref
Jane M. Simoni, Kenneth Tapia, Sung-Jae Lee, Susan M. Graham, Kristin Beima-Sofie, Zahra H. Mohamed, Joan Christodoulou, Rodney Ho & Ann C. Collier. (2019) A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.. AIDS and Behavior 24:4, pages 1226-1236.
Crossref
Crossref
John M. Humphrey, Violet Naanyu, Katherine R. MacDonald, Kara Wools-Kaloustian & Gregory D. Zimet. (2019) Stated-preference research in HIV: A scoping review. PLOS ONE 14:10, pages e0224566.
Crossref
Crossref
Inger M. Janssen, Ansgar Gerhardus, Milly A. Schröer-Günther & Fülöp Scheibler. (2015) A descriptive review on methods to prioritize outcomes in a health care context. Health Expectations 18:6, pages 1873-1893.
Crossref
Crossref
Michael D. Clark, Domino Determann, Stavros Petrou, Domenico Moro & Esther W. de Bekker-Grob. (2014) Discrete Choice Experiments in Health Economics: A Review of the Literature. PharmacoEconomics 32:9, pages 883-902.
Crossref
Crossref
H. Wouters, L. Van Dijk, E. C. G. Van Geffen, H. Gardarsdottir, A. M. Stiggelbout & M. L. Bouvy. (2014) Primary-care patients' trade-off preferences with regard to antidepressants. Psychological Medicine 44:11, pages 2301-2308.
Crossref
Crossref
H. Wouters, G.A. Maatman, L. Van Dijk, M.L. Bouvy, R. Vree, E.C.G. Van Geffen, J.W. Nortier & A.M. Stiggelbout. (2013) Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor-positive breast cancer. Annals of Oncology 24:9, pages 2324-2329.
Crossref
Crossref
AM Mills, A Antinori, B Clotet, J Fourie, G Herrera, C Hicks, JV Madruga, S Vanveggel, M Stevens & K Boven. (2013)
Neurological and psychiatric tolerability of rilpivirine (TMC278)
vs.
efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks
. HIV Medicine 14:7, pages 391-400.
Crossref
Crossref
Charles E. Cunningham, Ken Deal & Yvonne Chen. (2010) Adaptive Choice-Based Conjoint Analysis. The Patient: Patient-Centered Outcomes Research 3:4, pages 257-273.
Crossref
Crossref
Arwen H. Pieterse, Anne M. Stiggelbout & Corrie A.M. Marijnen. (2010) Methodologic evaluation of adaptive conjoint analysis to assess patient preferences: an application in oncology. Health Expectations 13:4, pages 392-405.
Crossref
Crossref
Marjorie Opuni, David Bishai, Glenda E. Gray, James A. McIntyre & Neil A. Martinson. (2009) Preferences for Characteristics of Antiretroviral Therapy Provision in Johannesburg, South Africa: Results of a Conjoint Analysis. AIDS and Behavior 14:4, pages 807-815.
Crossref
Crossref
Arwen H. Pieterse, Frank Berkers, Monique C.M. Baas-Thijssen, Corrie A.M. Marijnen & Anne M. Stiggelbout. (2010) Adaptive Conjoint Analysis as individual preference assessment tool: Feasibility through the internet and reliability of preferences. Patient Education and Counseling 78:2, pages 224-233.
Crossref
Crossref
Jean-Michel Molina, Jaime Andrade-Villanueva, Juan Echevarria, Ploenchan Chetchotisakd, Jorge Corral, Neal David, Graeme Moyle, Marco Mancini, Lisa Percival, Rong Yang, Alexandra Thiry & Donnie McGrath. (2008) Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. The Lancet 372:9639, pages 646-655.
Crossref
Crossref